Undercutting efforts of precision medicine: roadblocks to minority representation in breast cancer clinical trials Geetanjali SainiKeerthi GogineniRitu Aneja Review 02 June 2021 Pages: 605 - 611
Concurrent mutations associated with trastuzumab-resistance revealed by single cell sequencing Yan GaoNing WuBo Xu Preclinical study 27 April 2021 Pages: 613 - 624
Spectrum of PIK3CA/AKT mutations across molecular subtypes of triple-negative breast cancer Sandeep KumarAmanjit BalGurpreet Singh Preclinical study 05 May 2021 Pages: 625 - 633
The role of infiltrating lymphocytes in the neo-adjuvant treatment of women with HER2-positive breast cancer A. J. EustaceS. F. MaddenB. T. Hennessy Preclinical study Open access 13 May 2021 Pages: 635 - 645
Comparison of survival outcomes for axillary surgery extent based on intraoperative sentinel lymph node biopsy result after neoadjuvant chemotherapy for breast cancer Jung Whan ChunJisun KimSae Byul Lee Preclinical study 08 May 2021 Pages: 647 - 655
Bystander effects induced by electron beam-irradiated MCF-7 cells: a potential mechanism of therapy resistance Maryam FeghhiJafar RezaieNasrollah Jabbari Preclinical study 27 May 2021 Pages: 657 - 671
Unveiling the histopathologic spectrum of MRI-guided breast biopsies: an institutional pathological-radiological correlation Gustavo MorenoMariel MolinaJulie M. Jorns Preclinical study 27 May 2021 Pages: 673 - 680
Comparison of hormone-induced mRNA and protein biomarker expression changes in breast cancer cells Sarah M. BernhardtPallave DasariWendy V. Ingman Preclinical study 31 May 2021 Pages: 681 - 693
Combinatorial targeting of microRNA-26b and microRNA-101 exerts a synergistic inhibition on cyclooxygenase-2 in brain metastatic triple-negative breast cancer cells Rania HaratiAloïse MabondzoRifat Hamoudi Preclinical study 26 May 2021 Pages: 695 - 713
Adjuvant chemotherapy for breast cancer patients with axillary lymph node micrometastases Madeleine HetterichMichael GerkenAtanas Ignatov Clinical trial 15 March 2021 Pages: 715 - 727
Every Day Counts: a randomized pilot lifestyle intervention for women with metastatic breast cancer Patricia SheeanLauren MatthewsMelinda Stolley Clinical trial 19 March 2021 Pages: 729 - 741
Tumor levels of the mediators of ErbB2-driven anoikis resistance correlate with breast cancer relapse in patients receiving trastuzumab-based therapies Alexi SuretteByong Hoon YooKirill V. Rosen Clinical trial 16 March 2021 Pages: 743 - 758
Trastuzumab emtansine (T-DM1) versus trastuzumab in Chinese patients with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy for HER2-positive breast cancer in the phase 3 KATHERINE study Chiun-Sheng HuangYoungsen YangZhimin Shao Clinical trial 15 April 2021 Pages: 759 - 768
Monitoring serum estradiol levels in breast cancer patients during extended adjuvant letrozole treatment after five years of tamoxifen: a prospective trial Mária FaltinováLeena VehmanenJohanna Mattson Clinical trial 12 March 2021 Pages: 769 - 775
A qualitative study to evaluate physician attitudes regarding omission of surgery among exceptional responders to neoadjuvant systemic therapy for breast cancer (NRG-CC006) Laila A. GharzaiLauren A. SzczygielReshma Jagsi Clinical trial 19 March 2021 Pages: 777 - 784
Analysis of the tumor characteristics in young age breast cancer patients using collaborative stage data of the Korea Central Cancer Registry Junyup KimSeri HongSo-Youn Jung Epidemiology 18 February 2021 Pages: 785 - 792
Associations of one-carbon metabolism-related gene polymorphisms with breast cancer risk are modulated by diet, being higher when adherence to the Mediterranean dietary pattern is low Shang CaoZheng ZhuMing Wu Epidemiology 18 February 2021 Pages: 793 - 804
Refining breast cancer prognosis by incorporating age at diagnosis into clinical prognostic staging: introduction of a novel online calculator Helen M. JohnsonWilliam IrishJan H. Wong Epidemiology 20 February 2021 Pages: 805 - 814
Outcomes of HER2-positive non-metastatic breast cancer patients treated with anti-HER2 therapy without chemotherapy Susanna NguyS. Peter WuNaamit K. Gerber Epidemiology 15 February 2021 Pages: 815 - 830
Evidence for racial/ethnic disparities in emergency department visits following breast cancer surgery among women in California: a population-based study Mary FalconeLihua LiuCaryn Lerman Epidemiology 06 March 2021 Pages: 831 - 841
Twenty-year risks of breast cancer-specific mortality for stage III breast cancer in the surveillance, epidemiology, and end results registry José P. LeoneBernardo A. LeoneNancy U. Lin Epidemiology 16 February 2021 Pages: 843 - 852
Survival of women diagnosed with breast cancer and who have survived a previous cancer Sandi L. PruittHong ZhuCaitlin C. Murphy Epidemiology 23 February 2021 Pages: 853 - 865
Time-varying effects of FOXA1 on breast cancer prognosis Qian-xin ChenYuan-zhong YangZe-fang Ren Epidemiology 18 February 2021 Pages: 867 - 875
Delayed initiation of adjuvant chemotherapy among women with breast cancer in Addis Ababa, Ethiopia Alem GebremariamMathewos AssefaAhmedin Jemal Epidemiology 18 February 2021 Pages: 877 - 882
Real-world evidence from a University Hospital system regarding the uptake of adjuvant pertuzumab and/or neratinib before and after their FDA approval Ericson StoenJodi KagiharaJennifer R. Diamond Epidemiology Open access 24 February 2021 Pages: 883 - 891
Cardiac assessment in Australian patients receiving (neo)adjuvant trastuzumab for HER2-positive early breast cancer: a population-based study Monica TangAndrea L. SchafferSallie-Anne Pearson Epidemiology 22 February 2021 Pages: 893 - 902
Recurrence rates in patients with HER2+ breast cancer who achieved a pathological complete response after neoadjuvant pertuzumab plus trastuzumab followed by adjuvant trastuzumab: a real-world evidence study Joyce O’ShaughnessyNicholas RobertAnita Fung Epidemiology 01 March 2021 Pages: 903 - 913
Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with node-positive breast cancer: guiding a more selective axillary approach Parinita. K. SwarnkarKefah Mokbel Letter to the Editor 05 May 2021 Pages: 915 - 916
Association between rice consumption and risk of cancer incidence in the California Teachers Study Rebecca J. Austin-DattaCarmen R. SmothermanLusine Yaghjyan Letter to the Editor 21 April 2021 Pages: 917 - 918
Patterns of invasive recurrence among patients originally treated for ductal carcinoma in situ by breast-conserving surgery versus mastectomy Parinita K. SwarnkarKefah Mokbel Letter to the Editor 29 April 2021 Pages: 919 - 920